DIR Return Create A Forum - Home
---------------------------------------------------------
MS Speaks
HTML https://msspeaks.createaforum.com
---------------------------------------------------------
*****************************************************
DIR Return to: ZEPOSIA (ozanimod)
*****************************************************
#Post#: 2856--------------------------------------------------
FDA approves ozanimod (Zeposia), oral treatment for MS, includin
g active SPMS
By: agate Date: March 26, 2020, 10:18 am
---------------------------------------------------------
Another MS drug is rolled out--with another name that isn't easy
to pronounce. Is it ze-PO-si-a or ze-po-SI-a?
From Multiple Sclerosis News Today (March 26, 2020):
HTML https://multiplesclerosisnewstoday.com/news-posts/2020/03/26/fda-approves-zeposia-ozanimod-oral-rrms-active-spms-cis-therapy/
#Post#: 2857--------------------------------------------------
Zeposia release delayed because of pandemic
By: agate Date: March 28, 2020, 12:34 am
---------------------------------------------------------
Zeposia won't be available just now after all because of the
COVID-19 pandemic, according to FiercePharma (March 27, 2020):
HTML https://www.fiercepharma.com/pharma/bristol-myers-investors-breathe-a-sigh-relief-as-fda-approves-celgene-s-ms-drug-ozanimod
#Post#: 2923--------------------------------------------------
Press release about availability of Zeposia
By: agate Date: June 2, 2020, 11:10 am
---------------------------------------------------------
A press release (June 1, 2020) about the availability of Zeposia
(ozanimod):
HTML https://news.bms.com/press-release/corporatefinancial-news/bristol-myers-squibb-announces-commercial-launch-and-availabil
#Post#: 3013--------------------------------------------------
Zeposia (ozanimod) preventing relapses in RMS patients after 3 y
ears according to trial data
By: agate Date: September 4, 2020, 12:32 am
---------------------------------------------------------
From Multiple Sclerosis News Today (September 3, 2020)--"Zeposia
still prevents relapses in relapsing multiple sclerosis patients
after 3 years, trial data show":
HTML https://bit.ly/3jIzYP4
*****************************************************